Ocular Therapeutix, Inc.
OCULNASDAQHealthcare● Active
$8.16
$-0.09(-1.09%)
Market Cap$1.8B
P/E Ratio—
52W High$16.44
52W Low$6.23
Ocular Therapeutix, Inc.（OCUL）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · OCUL · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $51.82M | $63.72M | $58.44M | $51.49M | $43.52M |
| Cost of Revenue | $6.57M | $5.63M | $5.28M | $4.54M | $4.41M |
| Gross Profit | $45.25M | $58.10M | $53.16M | $46.95M | $39.12M |
| Gross Margin %(computed) | 87.31% | 91.17% | 90.96% | 91.18% | 89.88% |
| Operating Expenses | |||||
| R&D Expenses | $197.10M | $127.64M | $61.05M | $53.46M | $50.08M |
| G&A Expenses | $64.38M | $60.65M | $33.94M | $67.98M | $31.88M |
| Total Operating Expenses | $315.39M | $229.88M | $135.54M | $125.61M | $117.15M |
| Operating Income | ($270.02M) | ($171.78M) | ($82.38M) | ($78.65M) | ($78.04M) |
| Operating Margin %(computed) | -521.04% | -269.57% | -140.96% | -152.74% | -179.30% |
| Interest Income | $18.36M | $20.28M | $3.98M | $0.80M | $0.03M |
| Interest Expense | $11.84M | $13.58M | $11.34M | $7.02M | $6.67M |
| Income Before Tax | ($265.94M) | ($193.51M) | ($80.74M) | ($71.04M) | ($6.55M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($265.94M) | ($193.51M) | ($80.74M) | ($71.04M) | ($6.55M) |
| Net Margin %(computed) | -513.17% | -303.67% | -138.14% | -137.95% | -15.06% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.42 | $-1.22 | $-1.09 | $-1.04 | $-1.05 |
| Wtd Avg Shares | 187.24M | 158.26M | 79.83M | 76.88M | 76.39M |
| EBITDA | ($249.78M) | ($176.14M) | ($66.42M) | ($61.91M) | $2.54M |
| EBITDA Margin %(computed) | -481.99% | -276.42% | -113.64% | -120.22% | 5.83% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解Ocular Therapeutix, Inc.
关于Ocular Therapeutix, Inc.（OCUL）损益表
Ocular Therapeutix, Inc.（OCUL）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，OCUL实现营收$0.05B，毛利润$0.05B（毛利率87.31%），净利润($0.27B)（净利率-513.17%）。
常见问题
OCUL · 4 问Ocular Therapeutix, Inc.（OCUL）2025财年营收为$0.05B，同比down18.7%。
OCUL revenueOCUL salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08